Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management....
This technique allows for highly precise radiation delivery while minimising exposure to surrounding healthy tissue...
Commercial partnership expected to accelerate adoption of SimBioSys' AI-powered surgical visualisation platform following recent FDA clearance of TumorSight Viz 1.3 ...
Photon-counting CT (PCCT) is considered a breakthrough in next-generation imaging...
The partnership reflects an exciting strategic alignment between the two companies...
The OBM rapid A1C is the first portable device to measure glycated haemoglobin (A1C) using microfluidic technology...
Advanced mobile surgical solutions to improve access to eye care for veterans, active duty and DoD personnel...
Use of the Chemo Mouthpiece resulted in a 46 per cent reduction in patient-reported oral pain symptoms compared to the control group...
Introducing the first scalable solution enabling real-time interventions for medication non-adherence...
This milestone acknowledges Triojection's potential to offer a highly effective, more accessible, and safer treatment for patients suffering from contained lumbar disc herniations...
